AZN vs DECK · P/E 28, $288.38B cap vs P/E 16, rev $4.99B
AstraZeneca PLC (AZN) versus Deckers Outdoor Corporation (DECK) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Deckers Outdoor Corporation (DECK) is a footwear & accessories company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported DECK revenue for 2025-03-31 was $4.99B. Net income was $966.1M. Revenue was up 419.5% from 2024-03-31 to 2025-03-31. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
Not investment advice. Open the AZN and DECK stock pages for the full models.
Not investment advice.